chr19-38915622-T-C
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_017827.4(SARS2):c.1541A>G(p.Gln514Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q514L) has been classified as Uncertain significance.
Frequency
Consequence
NM_017827.4 missense
Scores
Clinical Significance
Conservation
Publications
- hyperuricemia-pulmonary hypertension-renal failure-alkalosis syndromeInheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, PanelApp Australia, Orphanet
- mitochondrial diseaseInheritance: AR Classification: MODERATE Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_017827.4. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SARS2 | TSL:1 MANE Select | c.1541A>G | p.Gln514Arg | missense | Exon 16 of 16 | ENSP00000221431.6 | Q9NP81-1 | ||
| ENSG00000269547 | TSL:2 | c.1748A>G | p.Gln583Arg | missense | Exon 20 of 20 | ENSP00000472465.1 | M0R2C6 | ||
| SARS2 | TSL:5 | c.1541A>G | p.Gln514Arg | missense | Exon 16 of 17 | ENSP00000468865.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 32
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at